Heavy Metals and Trajectories of Anti-Müllerian Hormone During the Menopausal Transition
The Journal of Clinical Endocrinology & Metabolism · 15.10.2024 · 109 (11) · e2057-e2064
DOI: 10.1210/clinem/dgad756 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 25.01.2024. Verfasst von Ning Ding und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA. Hauptthemen laut MEDLINE: Anti-Mullerian Hormone, Metals, Heavy, Menopause, Ovarian Reserve. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIOSH CDC HHS, NIEHS NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Background
Experimental and epidemiological studies have linked metals with women's reproductive aging, but the mechanisms are not well understood. Disrupted ovarian folliculogenesis and diminished ovarian reserve could be a pathway through which metals impact reproductive hormones and outcomes.
Objective
The study aimed to evaluate the associations of heavy metals with anti-Müllerian hormone (AMH), a marker of ovarian reserve.
Methods
The study included 549 women from the Study of Women's Health Across the Nation with 2252 repeated AMH measurements from 10 to 0 years before the final menstrual period (FMP). Serum AMH concentrations were measured using picoAMH ELISA. Urinary concentrations of arsenic, cadmium, mercury, and lead were measured using high-resolution inductively coupled plasma mass spectrometry. Multivariable linear mixed regressions modeled AMH as a function of time before the FMP interaction terms between metals and time to the FMP were also included.
Results
Adjusting for confounders, compared with those in the lowest tertile, women in the highest tertile of urinary arsenic or mercury concentrations had lower AMH concentrations at the FMP (percent change: −32.1%; 95% CI, −52.9 to −2.2, P-trend = .03 for arsenic; percent change: −40.7%; 95% CI, −58.9 to −14.5, P-trend = .005 for mercury). Higher cadmium and mercury were also associated with accelerated rates of decline in AMH over time (percent change per year: −9.0%; 95% CI, −15.5 to −1.9, P-trend = .01 for cadmium; −7.3%; 95% CI, −14.0 to −0.1, P-trend = .04 for mercury).
Conclusion
Heavy metals including arsenic, cadmium, and mercury may act as ovarian toxicants by diminishing ovarian reserve in women approaching the FMP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Obstetrics and Gynecology, School of Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Public Health Sciences, University of California, Davis, School of Medicine, Davis, CA 95616, USA.
- Department of Environmental Health Sciences, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.
ORCID-Profile: Ning Ding, Xin Wang, Sung Kyun Park
Förderung
- NIOSH CDC HHS
- NIEHS NIH HHS
- NIA NIH HHS
- NCRR NIH HHS
- NIH HHS
- NINR NIH HHS
- Study of Women's Health Across the Nation
- National Institutes of Health
Zitieren
APA
Ding, N., Wang, X., Harlow, S. D., Randolph, J. F., Gold, E. B., & Park, S. K. (2024). Heavy Metals and Trajectories of Anti-Müllerian Hormone During the Menopausal Transition. The Journal of Clinical Endocrinology & Metabolism, 109(11), e2057-e2064. https://doi.org/10.1210/clinem/dgad756
Vancouver
Ding N, Wang X, Harlow SD, Randolph JF, Gold EB, Park SK. Heavy Metals and Trajectories of Anti-Müllerian Hormone During the Menopausal Transition. The Journal of Clinical Endocrinology & Metabolism. 2024;109(11):e2057-e2064. doi:10.1210/clinem/dgad756
BibTeX
@article{Ding2024,
author = {Ding, Ning and Wang, Xin and Harlow, Siobán D and Randolph, John F and Gold, Ellen B and Park, Sung Kyun},
title = {Heavy Metals and Trajectories of Anti-Müllerian Hormone During the Menopausal Transition},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
volume = {109},
number = {11},
pages = {e2057--e2064},
doi = {10.1210/clinem/dgad756}
}
EUVIMED